ATE253925T1 - Zusammensetzung enthaltend sojaprotein, diätfasern und phytoestrogen sowie ihre verwendung zur vorbeugung und/oder behandlung von kardiovaskulären erkrankungen - Google Patents

Zusammensetzung enthaltend sojaprotein, diätfasern und phytoestrogen sowie ihre verwendung zur vorbeugung und/oder behandlung von kardiovaskulären erkrankungen

Info

Publication number: ATE253925T1
Authority: AT; Austria
Prior art keywords: soy protein; composition; dietary fibers; phytoestrogen; cardiovascular diseases
Prior art date: 1998-11-25

Application number

AT99972541T

Other languages

English (en)

Inventor

Lars Henrik Hoie

Original Assignee

Nutri Pharma As

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1998-11-25

Filing date

1999-11-25

Publication date

2003-11-15

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26064781&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE253925(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

1999-11-25 Application filed by Nutri Pharma As filed Critical Nutri Pharma As

2003-11-15 Application granted granted Critical

2003-11-15 Publication of ATE253925T1 publication Critical patent/ATE253925T1/de

Links

108010073771 Soybean Proteins Proteins 0.000 title abstract 4
229940001941 soy protein Drugs 0.000 title abstract 4
235000013325 dietary fiber Nutrition 0.000 title abstract 3
239000003075 phytoestrogen Substances 0.000 title abstract 3
208000024172 Cardiovascular disease Diseases 0.000 title abstract 2
102000015781 Dietary Proteins Human genes 0.000 title 1
238000008214 LDL Cholesterol Methods 0.000 abstract 2
108010028554 LDL Cholesterol Proteins 0.000 abstract 2
150000001875 compounds Chemical class 0.000 abstract 2
210000002966 serum Anatomy 0.000 abstract 2
206010003210 Arteriosclerosis Diseases 0.000 abstract 1
235000010469 Glycine max Nutrition 0.000 abstract 1
244000068988 Glycine max Species 0.000 abstract 1
108010023302 HDL Cholesterol Proteins 0.000 abstract 1
208000011775 arteriosclerosis disease Diseases 0.000 abstract 1
HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 abstract 1
239000000835 fiber Substances 0.000 abstract 1
GOMNOOKGLZYEJT-UHFFFAOYSA-N isoflavone Chemical compound C=1OC2=CC=CC=C2C(=O)C=1C1=CC=CC=C1 GOMNOOKGLZYEJT-UHFFFAOYSA-N 0.000 abstract 1
CJWQYWQDLBZGPD-UHFFFAOYSA-N isoflavone Natural products C1=C(OC)C(OC)=CC(OC)=C1C1=COC2=C(C=CC(C)(C)O3)C3=C(OC)C=C2C1=O CJWQYWQDLBZGPD-UHFFFAOYSA-N 0.000 abstract 1
235000008696 isoflavones Nutrition 0.000 abstract 1
235000016709 nutrition Nutrition 0.000 abstract 1
UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
- A23L33/11—Plant sterols or derivatives thereof, e.g. phytosterols
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/185—Vegetable proteins
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
- A23L33/21—Addition of substantially indigestible substances, e.g. dietary fibres
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Engineering & Computer Science (AREA)
Chemical & Material Sciences (AREA)
Mycology (AREA)
Polymers & Plastics (AREA)
Food Science & Technology (AREA)
Nutrition Science (AREA)
Natural Medicines & Medicinal Plants (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Botany (AREA)
Bioinformatics & Cheminformatics (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Heart & Thoracic Surgery (AREA)
Cardiology (AREA)
Microbiology (AREA)
Diabetes (AREA)
Alternative & Traditional Medicine (AREA)
Biotechnology (AREA)
Medical Informatics (AREA)
Hematology (AREA)
Epidemiology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Vascular Medicine (AREA)
Urology & Nephrology (AREA)
Obesity (AREA)
Coloring Foods And Improving Nutritive Qualities (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicines Containing Plant Substances (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)

AT99972541T 1998-11-25 1999-11-25 Zusammensetzung enthaltend sojaprotein, diätfasern und phytoestrogen sowie ihre verwendung zur vorbeugung und/oder behandlung von kardiovaskulären erkrankungen ATE253925T1 (de)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
DKPA199801555		1998-11-25
DKPA199900855		1999-06-16
PCT/IB1999/001998 WO2000030665A1 (en)	1998-11-25	1999-11-25	Composition comprising soy protein, dietary fibres and a phytoestrogen compound and use thereof in the prevention and/or treatment of cardiovascular diseases

Publications (1)

Publication Number	Publication Date
ATE253925T1 true ATE253925T1 (de)	2003-11-15

Family

ID=26064781

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT99972541T ATE253925T1 (de)	1998-11-25	1999-11-25	Zusammensetzung enthaltend sojaprotein, diätfasern und phytoestrogen sowie ihre verwendung zur vorbeugung und/oder behandlung von kardiovaskulären erkrankungen

Country Status (11)

Country	Link
US (1)	US6630178B1 (de)
EP (1)	EP1133308B1 (de)
JP (1)	JP2002530347A (de)
AT (1)	ATE253925T1 (de)
AU (1)	AU767245B2 (de)
BR (1)	BR9915687A (de)
CA (1)	CA2352585A1 (de)
DE (1)	DE69912833T2 (de)
HK (1)	HK1041635A1 (de)
NZ (1)	NZ511812A (de)
WO (1)	WO2000030665A1 (de)

Families Citing this family (73)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6733815B2 (en)	1999-04-16	2004-05-11	Cargill, Incorporated	Food ingredient containing wheat gluten, soy grits and soy flour
JP2002542192A (ja)	1999-04-20	2002-12-10	ボードオブトラスティース，サザンイリノイユニバーシティ	イソフラボンで臨床的な疾患を処置する方法
US7285297B1 (en)	1999-04-23	2007-10-23	Archer-Daniels-Midland Company	Method of reducing low density liproprotein cholesterol concentration
AU779014B2 (en) *	1999-04-23	2005-01-06	Archer-Daniels-Midland Company	Composition for and method of reducing low density lipoprotein cholesterol concentration
US6544566B1 (en)	1999-04-23	2003-04-08	Protein Technologies International, Inc.	Composition containing plant sterol, soy protein and isoflavone for reducing LDL cholesterol
US20020160060A1 (en) *	1999-04-26	2002-10-31	Mandy Kim Chen	Enriched spreads
AU4402600A (en) *	1999-05-18	2000-12-05	Rawlings, Anthony V.	Fat containing products
EP1274319B1 (de)	2000-04-14	2009-08-12	Mars, Incorporated	Zusammensetzungen und methoden zur verbesserung der vaskulären gesundheit
US6541522B2 (en)	2000-08-16	2003-04-01	Insmed Incorporated	Methods of using compositions containing hypotriglyceridemically active stilbenoids
US6933291B2 (en) *	2000-12-01	2005-08-23	N.V. Nutricia	Cholesterol lowering supplement
AUPR255401A0 (en) *	2001-01-16	2001-02-08	Novogen Research Pty Ltd	Regulation of lipids and/or bone density and compositions therefor
WO2002064809A2 (en)	2001-02-09	2002-08-22	Unilever N.V.	Process for the preparation of one or more statins by fermentation
FI115192B (fi) *	2001-02-26	2005-03-31	Oriola Oy	Funktionaalinen elintarvike ja sen valmistusmenetelmä
JP4256679B2 (ja) *	2001-03-16	2009-04-22	ノボゲンリサーチピーティーワイリミテッド	再狭窄の治療方法
FI113612B (fi) *	2001-04-25	2004-05-31	Moshe Meidan	Funktionaalinen elintarvike ja menetelmä sen valmistamiseksi
ATE358477T1 (de) *	2001-06-12	2007-04-15	Galephar M F	Oral anzuwendende arzneizusammensetzung enthaltend ein statinderivat
EP1443946A2 (de) *	2001-07-03	2004-08-11	Nutri Pharma ASA	Soja-enthaltende zusammensetzung und deren verwendung zur prävention und/oder behandlung von verschiedenen krankheiten
US6787151B2 (en) *	2001-08-10	2004-09-07	Lipton, Division Of Conopco, Inc.	Composition for lowering blood cholesterol
GB0125662D0 (en) *	2001-10-26	2001-12-19	Chapman Thomas B	Formultion
FI20012553A0 (fi)	2001-12-21	2001-12-21	Raisio Benecol Oy	Syötävät koostumukset
WO2003070006A1 (en) *	2002-02-22	2003-08-28	Nutri Pharma Asa	Bread comprising soy protein
AU2003206050A1 (en) *	2002-02-22	2003-09-09	Nutri Pharma Asa	Food products comprising soy protein
EP1480525A2 (de) *	2002-02-23	2004-12-01	Nutri Pharma ASA	Neue sojaproteinprodukte
US20030166614A1 (en) *	2002-03-01	2003-09-04	Harrison Stanley F.	Method for reducing cholesterol and triglycerides
CN104643057A (zh) *	2002-07-24	2015-05-27	儿童医院医疗中心	含有对映体牛尿酚的组合物和产物及其用途
US20040022876A1 (en) *	2002-07-30	2004-02-05	Nancy Green	Cardiovascular health enhancement with soy fortified citrus juice compositions
CA2438025A1 (en) *	2002-08-21	2004-02-21	Advanced Nutri-Tech Systems Inc.	Fruit sponge
US7371759B2 (en)	2003-09-25	2008-05-13	Bristol-Myers Squibb Company	HMG-CoA reductase inhibitors and method
US20050250734A1 (en) *	2003-11-07	2005-11-10	The Procter & Gamble Company	Compositions, kits, and methods for the treatment of conditions associated with elevated cholesterol levels
US7420059B2 (en)	2003-11-20	2008-09-02	Bristol-Myers Squibb Company	HMG-CoA reductase inhibitors and method
MD2518G2 (ro) *	2003-12-09	2005-06-30	Элеонора ВАТАМАН	Preparat medicamentos pentru reducerea concentratiei colesterolului in sange
EP1588659A3 (de) *	2004-01-16	2008-06-18	PM-International AG	Verfahren und System zur Überwachung bzw. Steuerung eines Diäterfolges
US7572805B2 (en)	2004-07-14	2009-08-11	Bristol-Myers Squibb Company	Pyrrolo(oxo)isoquinolines as 5HT ligands
RU2402243C2 (ru) *	2004-07-19	2010-10-27	Н.В. Нютрисиа	Препарат для применения аспартата для регулирования уровней глюкозы в крови
CN101014254A (zh) *	2004-08-23	2007-08-08	荷兰联合利华有限公司	包含他汀的组合物
US7517991B2 (en)	2004-10-12	2009-04-14	Bristol-Myers Squibb Company	N-sulfonylpiperidine cannabinoid receptor 1 antagonists
US7368458B2 (en)	2005-01-12	2008-05-06	Bristol-Myers Squibb Company	Bicyclic heterocycles as cannabinoid receptor modulators
WO2006076598A2 (en)	2005-01-12	2006-07-20	Bristol-Myers Squibb Company	Bicyclic heterocycles as cannabinoid receptor modulators
WO2006076569A2 (en)	2005-01-12	2006-07-20	Bristol-Myers Squibb Company	Bicyclic heterocycles as cannabinoid receptor modulators
US20060160850A1 (en)	2005-01-18	2006-07-20	Chongqing Sun	Bicyclic heterocycles as cannabinoid receptor modulators
EP1846410B1 (de)	2005-02-10	2009-01-21	Bristol-Myers Squibb Company	Dihydrochinazolinone als 5ht-modulatoren
US20060280840A1 (en) *	2005-05-24	2006-12-14	Robertson Marion G	Universal protein formulation meeting multiple dietary needs for optimal health and enhancing the human immune system
US7452892B2 (en)	2005-06-17	2008-11-18	Bristol-Myers Squibb Company	Triazolopyrimidine cannabinoid receptor 1 antagonists
US7629342B2 (en)	2005-06-17	2009-12-08	Bristol-Myers Squibb Company	Azabicyclic heterocycles as cannabinoid receptor modulators
TW200726765A (en)	2005-06-17	2007-07-16	Bristol Myers Squibb Co	Triazolopyridine cannabinoid receptor 1 antagonists
US7317012B2 (en)	2005-06-17	2008-01-08	Bristol-Myers Squibb Company	Bicyclic heterocycles as cannabinoind-1 receptor modulators
US7632837B2 (en)	2005-06-17	2009-12-15	Bristol-Myers Squibb Company	Bicyclic heterocycles as cannabinoid-1 receptor modulators
US7795436B2 (en)	2005-08-24	2010-09-14	Bristol-Myers Squibb Company	Substituted tricyclic heterocycles as serotonin receptor agonists and antagonists
AR056155A1 (es)	2005-10-26	2007-09-19	Bristol Myers Squibb Co	Antagonistas del receptor 1 de la hormona de concentracion de melanina no basica
TW200729300A (en) *	2005-11-30	2007-08-01	Nuflare Technology Inc	Film-forming method and film-forming equipment
US7553836B2 (en)	2006-02-06	2009-06-30	Bristol-Myers Squibb Company	Melanin concentrating hormone receptor-1 antagonists
US8110231B2 (en) *	2006-04-10	2012-02-07	Kraft Foods Global Brands Llc	Methods for making improved texture cereal bars
US8598111B2 (en)	2006-09-15	2013-12-03	Soy Labs, Llc	Products and methods using soy peptides to lower total and LDL cholesterol levels
CN101522022B (zh)	2006-09-16	2013-05-08	大豆实验室公司	利用大豆肽降低总胆固醇水平和ldl胆固醇水平的产品和方法
US9101161B2 (en) *	2006-11-02	2015-08-11	The Coca-Cola Company	High-potency sweetener composition with phytoestrogen and compositions sweetened therewith
JP5355395B2 (ja) *	2007-06-13	2013-11-27	大塚製薬株式会社	エクオール含有抽出物及びその製造方法、エクオール抽出方法、並びにエクオールを含む食品
US20090011994A1 (en)	2007-07-06	2009-01-08	Bristol-Myers Squibb Company	Non-basic melanin concentrating hormone receptor-1 antagonists and methods
PE20091928A1 (es)	2008-05-29	2009-12-31	Bristol Myers Squibb Co	Tienopirimidinas hidroxisustituidas como antagonistas de receptor-1 de hormona concentradora de melanina no basicos
MX2011009852A (es)	2009-03-27	2011-09-29	Bristol Myers Squibb Co	Metodos para prevenir episodios cardiovasculares adversos mayores con inhibidores de dipeptidil peptidasa iv.
TWI426915B (zh)	2010-12-29	2014-02-21	Univ Nat Pingtung Sci & Tech	台灣藜用以製備治療高血脂症及高膽固醇症之藥物的用途及其醫藥組成物
US9499482B2 (en)	2012-09-05	2016-11-22	Bristol-Myers Squibb Company	Pyrrolone or pyrrolidinone melanin concentrating hormone receptor-1 antagonists
EP2892896B1 (de)	2012-09-05	2016-06-29	Bristol-Myers Squibb Company	Pyrrolon- oder pyrrolidinon-antagonisten des melaninkonzentrierenden hormonrezeptor-1
WO2014145086A2 (en)	2013-03-15	2014-09-18	Galvez Alfredo Flores	Products and methods using lunasin-enriched soy extract mixtures to reduce free fatty acid levels, increase leptin levels and increase adiponectin levels in plasma
SG11201607831TA (en)	2014-03-26	2016-10-28	Abbott Lab	Nutritional supplement powder
USD767244S1 (en)	2015-09-03	2016-09-27	The J.M. Smucker Company	Coated food product
USD767243S1 (en)	2015-09-03	2016-09-27	The J.M. Smucker Company	Coated food product
USD767241S1 (en)	2015-09-03	2016-09-27	The J.M. Smucker Company	Coated food product
USD767242S1 (en)	2015-09-03	2016-09-27	The J.M Smucker Company	Coated food product
CN108697139A (zh)	2016-02-29	2018-10-23	雅培制药有限公司	营养补充粉
MA53175A (fr)	2018-07-19	2021-05-26	Astrazeneca Ab	Méthodes de traitement de hfpef au moyen de dapagliflozine et compositions comprenant celle-ci
WO2021064107A1 (en)	2019-10-02	2021-04-08	Norvia Nutrition Ltd.	Composition comprising soy and use thereof in the prevention and/or treatment of microvascular or lipoprotein related diseases, microcardiovascular diseases, atherosclerosis, hypertension, and in patients with such cardiovascular disorders suffering from alzheimer and dementia, overweight and obesity, type 2 diabetes, asthma and other disorders
CN119095592A (zh) *	2022-04-28	2024-12-06	绿石生物科学公司	大麻素的不良心血管作用的治疗
US20250170154A1 (en)	2023-11-28	2025-05-29	GreenStone Biosciences, Inc.	Genistein phosphate derivatives

Family Cites Families (30)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR2395288A1 (fr)	1977-06-23	1979-01-19	Ppn	Nouvelles compositions therapeutiques destinees notamment a la prevention et au traitement des maladies de plethore
US4557927A (en)	1983-03-10	1985-12-10	Kabushiki Kaisha Hoyashibara	Food products and process for producing same
FR2543550B1 (fr)	1983-04-01	1985-08-09	Cortial	Nouveaux derives de la tetrahydroxy-3', 4',5,7 flavone, leur methode de preparation et leur emploi therapeutique
JPS62201882A (ja)	1985-11-18	1987-09-05	Yamanouchi Pharmaceut Co Ltd	イソフラボン誘導体
US4818558A (en)	1987-08-04	1989-04-04	Worthington Foods, Inc.	Fiber/tofu food product and method for making the same
JPH0714927B2 (ja)	1988-04-06	1995-02-22	キッコーマン株式会社	イソフラボン化合物の製造法
EP0656786B2 (de)	1992-05-19	2014-04-23	Novogen Research Pty Ltd	Verwendung von isoflavon phyto-östrogen extrakten von soja oder klee
DK171752B1 (da)	1992-07-06	1997-05-12	Birgitte Stilling	Brødlignende produkt med blodsukkersænkende virkning til diabetikere samt pulverformig blanding til anvendelse ved fremstilling deraf
WO1994023716A1 (en)	1993-04-16	1994-10-27	Tufts University School Of Medicine	Method for treatment of menopausal and premenstrual symptoms
US6140469A (en)	1993-10-12	2000-10-31	Protein Technologies International, Inc.	Protein isolate having an increased level of isoflavone compounds and process for producing the same
BR9407822A (pt)	1993-10-12	1997-05-06	Protein Tech Int	Processo para produção de um soro de leite coalhado de proteina vegetal enriquecido com aglucono isoflavona soro de leite coalhado enriquecido com aglucono isoflavona proteina de soro de leite coalhado enriquecido com aglucono isoflavona e processo para a recuperação em uma proteina de leite coalhado de pelo mones 50% de uma isoflavona de um material de proteina vegetal
CN1055931C (zh)	1993-10-12	2000-08-30	蛋白质技术国际公司	富含糖苷配基异黄酮植物蛋白浓缩物及其制备方法
CA2173743A1 (en)	1993-10-12	1995-04-20	Jerome L. Shen	An aglucone isoflavone enriched vegetable protein extract and isolate and process for producing
US5320949A (en)	1993-10-12	1994-06-14	Protein Technologies International, Inc.	Process for producing aglucone isoflavone enriched vegetable protein fiber
CN1102991A (zh) *	1993-11-24	1995-05-31	李良云	纯天然减肥保健饮料
US5589182A (en)	1993-12-06	1996-12-31	Tashiro; Renki	Compositions and method of treating cardio-, cerebro-vascular and alzheimer's diseases and depression
US5463283A (en)	1994-05-24	1995-10-31	Bkl, Inc.	Drive circuit for electroluminescent lamp
AU3689095A (en)	1994-10-03	1996-04-26	Schouten Industries B.V.	Food and health products
US5516528A (en)	1995-01-13	1996-05-14	Wake Forest University	Dietary phytoestrogen in estrogen replacement therapy
IL115110A (en)	1995-08-30	1997-08-14	Chajuss Daniel	Soy molasses
PL184852B1 (pl)	1996-02-29	2002-12-31	Nutri Pharma As	Kompozycja na bazie składników soi
US5702752A (en)	1996-03-13	1997-12-30	Archer Daniels Midland Company	Production of isoflavone enriched fractions from soy protein extracts
PT906029E (pt)	1996-04-09	2002-11-29	Du Pont	Produto de proteina de soja enriquecido em isoflavona e metodo para o seu fabrico
TW425285B (en) *	1996-06-10	2001-03-11	Viva America Marketing Inc	Fish oil and garlic nutritive supplement
WO1998003084A1 (en) *	1996-07-18	1998-01-29	Nutricor, Inc.	Nutritious food preparations and methods for making them
US5654011A (en)	1996-07-30	1997-08-05	Energetics, Inc.	Dietary supplements
US5726034A (en)	1996-09-06	1998-03-10	Protein Technologies International, Inc.	Aglucone isoflavone enriched vegetable protein extract and protein material, and high genistein and daidzein content materials and process for producing the same
DE69818594T2 (de)	1997-06-23	2004-09-23	Société des Produits Nestlé S.A.	Verwendung einer nutritiven Zusammensetzung zur Herstellung einer flüssigen Zusammensetzung für Diabetiker
US5855892A (en) *	1997-09-19	1999-01-05	Potter; Susan M.	Method for decreasing LDL-cholesterol concentration and increasing HDL-cholesterol concentration in the blood to reduce the risk of atherosclerosis and vascular disease
WO2000030664A1 (en) *	1998-11-25	2000-06-02	Nutri Pharma Asa	Composition comprising soy protein, dietary fibres and a phytoestrogen compound and use thereof in the prevention and/or treatment of pulmonary diseases

1999
- 1999-11-25 CA CA002352585A patent/CA2352585A1/en not_active Abandoned
- 1999-11-25 JP JP2000583548A patent/JP2002530347A/ja active Pending
- 1999-11-25 WO PCT/IB1999/001998 patent/WO2000030665A1/en not_active Ceased
- 1999-11-25 NZ NZ511812A patent/NZ511812A/en unknown
- 1999-11-25 US US09/856,883 patent/US6630178B1/en not_active Expired - Fee Related
- 1999-11-25 AU AU14047/00A patent/AU767245B2/en not_active Ceased
- 1999-11-25 EP EP99972541A patent/EP1133308B1/de not_active Revoked
- 1999-11-25 BR BR9915687-3A patent/BR9915687A/pt not_active IP Right Cessation
- 1999-11-25 AT AT99972541T patent/ATE253925T1/de not_active IP Right Cessation
- 1999-11-25 DE DE69912833T patent/DE69912833T2/de not_active Expired - Fee Related
- 1999-11-25 HK HK02101651.6A patent/HK1041635A1/zh unknown

Also Published As

Publication number	Publication date
EP1133308B1 (de)	2003-11-12
BR9915687A (pt)	2001-12-04
JP2002530347A (ja)	2002-09-17
NZ511812A (en)	2003-11-28
CA2352585A1 (en)	2000-06-02
US6630178B1 (en)	2003-10-07
DE69912833T2 (de)	2004-09-23
WO2000030665A1 (en)	2000-06-02
DE69912833D1 (de)	2003-12-18
AU1404700A (en)	2000-06-13
HK1041635A1 (zh)	2002-07-19
AU767245B2 (en)	2003-11-06
EP1133308A1 (de)	2001-09-19

Legal Events

Date	Code	Title	Description
2004-05-15	RER	Ceased as to paragraph 5 lit. 3 law introducing patent treaties

Publication	Publication Date	Title
ATE253925T1 (de)	2003-11-15	Zusammensetzung enthaltend sojaprotein, diätfasern und phytoestrogen sowie ihre verwendung zur vorbeugung und/oder behandlung von kardiovaskulären erkrankungen
DE69914947D1 (de)	2004-03-25	Zusammensetzung enthaltend sojaprotein, diätfasern und phytoestrogen sowie ihre verwendung zur vorbeugung und/oder behandlung von typ ii diabetes, des metabolischen syndroms und assozierten kardiovaskulären erkrankungen
DE69908809D1 (de)	2003-07-17	Verwendung einer zusammensetzung enthaltend sojaprotein, diätfasern und phytoestrogen zur vorbeugung und/oder behandlung von lungenerkrankungen
CA2286655A1 (en)	1998-10-22	Tissue decellularization
ATE198405T1 (de)	2001-01-15	Zusammensetzung, die als nahrungsmittel oder zur senkung des serumlipidspiegels geeignet ist
DE60220145D1 (de)	2007-06-28	Verwendung eines mutterkrautextrakts zur regulierung der hautalterung
DE69822919D1 (de)	2004-05-13	Spezifische Antikörper zur Verwendung in der Herstellung pharmazeutischer Zusammensetzungen nützlich für die Vorbeugung oder Behandlung von Gastritis, Magen- und Zwölffingerdarmgeschwüren
EP0903143A3 (de)	1999-05-06	Verwendung von Daidzein zur Herstellung eines Arzneimittels zur Erhöhung des HDL Cholesterolniveaus
ATE398983T1 (de)	2008-07-15	Teildemineralisierte kortikale knochenkonstruktionen
EP1025850A4 (de)	2002-08-14	Isoflavon-enthaltende zusammensetzungen
ATE277034T1 (de)	2004-10-15	Liponsaürederivate und deren verwendung bei der behandlung von krankheiten
MY130670A (en)	2007-07-31	4-carboxyamino-2-substituted-1,2,3,4-tetrahydroquinolines
ATE258549T1 (de)	2004-02-15	Oxazolidindion-derivate, ihre herstellung und verwendung
BR0116376B1 (pt)	2013-04-30	composiÇço de perfume, produto de consumo, composiÇÕes para tratamento de tecido, de produto pessoal, para tratamento de superfÍcie dura e para tratamento de ar, e, mÉtodo nço terapÊutico para proporcionar benefÍcios de humor positivo, particularmente, benefÍcios de relaxamento, a um indivÍduo.
DE69814431D1 (de)	2003-06-12	3,3-diarylpropylamine , ihre verwendung und herstellung
DE59711006D1 (de)	2003-12-18	Emulgatormischungen und deren verwendung zur herstellung von pit-emulsionen
ES2152072T3 (es)	2001-01-16	Compuesto nutritivo mejorado resultado de la maceracion de maiz y su procedimiento de obtencion.
ATE219073T1 (de)	2002-06-15	Benzopyran derivate mit leukotrien- antagonistischer wirkung
TR199802171T2 (xx)	1999-02-22	Geli�tirilmi� f�r�n-apreli parmak patates k�zartmalar�n�n haz�rlanmas� i�in bir i�lem.
ATE242770T1 (de)	2003-06-15	Neue alpha-hydroxysäurederivate, ihre herstellung und verwendung
ATE201826T1 (de)	2001-06-15	Mischungen ausgehend von eugenia jambolana lamarck samen, herstellung und verwendung solcher mischungen sowie einiger inhaltsstoffe als medikamente
DE69517345D1 (de)	2000-07-13	Abziehbarer Verbundstoff und seiner Verwendung bei der Herstellung von Ausgleichsscheiben
DE59711704D1 (de)	2004-07-15	Neue carbonsäurederivate, ihre herstellung und verwendung
WO2000026399A3 (de)	2000-08-10	Verfahren zur herstellung von quercetin- und isoquercetin-derivaten
DE69904567D1 (de)	2003-01-30	Lipidmischung sowie ihre verwendung